a developer of novel disease-modifying therapeutic for alzheimer's and other degenerative diseases
Industry Biotechnology
A.I.dvisor tells us that QNCX and MNPR have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that QNCX and MNPR's prices will move in lockstep.
Ticker / NAME | Correlation To QNCX | 1D Price Change % | ||
---|---|---|---|---|
QNCX | 100% | +19.50% | ||
MNPR - QNCX | 28% Poorly correlated | -5.20% | ||
KOD - QNCX | 28% Poorly correlated | -3.64% | ||
LQDA - QNCX | 24% Poorly correlated | -2.39% | ||
MDXG - QNCX | 23% Poorly correlated | +23.56% | ||
FENC - QNCX | 22% Poorly correlated | -1.79% | ||
More |